GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » ACME Laboratories Ltd (DHA:ACMELAB) » Definitions » Other Operating Expense

ACME Laboratories (DHA:ACMELAB) Other Operating Expense : BDT3,505 Mil (TTM As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is ACME Laboratories Other Operating Expense?

ACME Laboratories's Other Operating Expense for the three months ended in Mar. 2024 was BDT37 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was BDT3,505 Mil.

ACME Laboratories's quarterly Other Operating Expense declined from Jun. 2023 (BDT1,768 Mil) to Sep. 2023 (BDT1,701 Mil) and declined from Sep. 2023 (BDT1,701 Mil) to Mar. 2024 (BDT37 Mil).

ACME Laboratories's annual Other Operating Expense increased from Jun. 2021 (BDT3,449 Mil) to Jun. 2022 (BDT4,300 Mil) and increased from Jun. 2022 (BDT4,300 Mil) to Jun. 2023 (BDT5,191 Mil).


ACME Laboratories Other Operating Expense Historical Data

The historical data trend for ACME Laboratories's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ACME Laboratories Other Operating Expense Chart

ACME Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Other Operating Expense
Get a 7-Day Free Trial 2,207.60 2,616.87 3,448.59 4,299.99 5,191.10

ACME Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.44 34.75 1,767.62 1,700.72 36.62

ACME Laboratories Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT3,505 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ACME Laboratories Other Operating Expense Related Terms

Thank you for viewing the detailed overview of ACME Laboratories's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


ACME Laboratories (DHA:ACMELAB) Business Description

Traded in Other Exchanges
N/A
Address
1/4, Kallayanpur, Mirpur Road, Court de la ACME, Dhaka, BGD, 1207
ACME Laboratories Ltd is engaged in the manufacturing, marketing, and distribution of generic pharmaceutical products in Bangladesh. The company offers pharmaceutical, ayurvedic, herbal, nutraceutical products, and veterinary products. It produces various forms of dosage including tablet, capsule, dry syrup, cream, ointment, powder and injection among others.

ACME Laboratories (DHA:ACMELAB) Headlines

No Headlines